Commonly prescribed thyroid drug levothyroxine was linked with bone mass and bone density loss in a cohort of older adults in ...

Authors say findings may be due to relative excess of thyroid hormone even when treatment is targeted to reference range goals ...

The loss of bone mineral density and bone mass is called osteoporosis, a disease that affects an estimated 10 million ...

Recent research has highlighted the bone-health risks of taking thyroid medication, prescribed to 23 million Americans.

Prescribed to treat hypothyroidism and thyroid cancer, around 7% of the U.S. population takes levothyroxine. The drug is a ...

A new study reveals a potential link between levothyroxine, a common treatment for underactive thyroid, and bone loss in ...

The researchers used the Baltimore Longitudinal Study of Aging, a prospective cohort study of community-dwelling older adults.

Levothyroxine — marketed under brand names such as Synthroid — is the second-most commonly prescribed medication among older adults in the US. It’s consumed by about 7% of the US population.

Amid a rise in contagious diseases across Karnataka, a shortage of life-saving drugs is causing concern. Over 250 essential ...

Levothyroxine, the second-most-commonly prescribed medication for older adults in the U.S., has been linked to lower bone density.

New research suggests that a thyroid medication often prescribed to older Americans may be linked to a common problem in old ...